Literature DB >> 2904349

Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas.

H P Wang1, C E Rogler.   

Abstract

Normal liver and hepatocellular carcinoma (HCC) genotypes were compared at loci on most of the human chromosomes with probes that detect restriction fragment length polymorphisms. Six of fourteen tumors exhibited loss of heterozygosity of one or more markers on 11p. Ten patients were informative for loci on 13q, and 5 of these 10 exhibited loss of heterozygosity for one or more of the 13q markers. Altogether, 9 of the 14 patients showed loss of a polymorphic allele for one or more loci on either 11p or 13q. A survey of loci on 16 additional chromosomes indicated that the deletions were not due to a general loss of heterozygosity in HCCs. Quantitative densitometry showed that each of the 10 deletions resulted in hemizygosity (no reduplication) of the remaining allele in tumor tissue. In contrast to hereditary embryonal tumors, in which reduplication of the remaining chromosome is the rule, simple deletion appears to be the primary mechanism responsible for the loss of heterozygosity in these adult, nonhereditary HCCs. These data show that HCCs arising in hepatitis B virus carriers are a genetically heterogeneous group of tumors, some of which may arise through 13q alterations, some through 11p alterations, some with both chromosomes altered, and some with both intact.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904349     DOI: 10.1159/000132593

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  30 in total

1.  Mapping of 262 DNA markers into 24 intervals on human chromosome 11.

Authors:  A Tanigami; T Tokino; S Takiguchi; M Mori; T Glaser; J W Park; C Jones; Y Nakamura
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

2.  Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma.

Authors:  K Ashida; Y Kishimoto; K Nakamoto; K Wada; G Shiota; Y Hirooka; Y Kamisaki; T Itoh; H Kawasaki
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Isolation and mapping of 62 new RFLP markers on human chromosome 11.

Authors:  T Tokino; E Takahashi; M Mori; A Tanigami; T Glaser; J W Park; C Jones; T Hori; Y Nakamura
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

4.  Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks.

Authors:  C Martins; M A Kedda; M C Kew
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

5.  Genetic mapping of Afr2 (Rif): regulator of gene expression in liver regeneration.

Authors:  D K Jin; M H Feuerman
Journal:  Mamm Genome       Date:  1998-03       Impact factor: 2.957

6.  Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma.

Authors:  K H Buetow; J C Murray; J L Israel; W T London; M Smith; M Kew; V Blanquet; C Brechot; A Redeker; S Govindarajah
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma.

Authors:  Y Kishimoto; G Shiota; K Wada; M Kitano; K Nakamoto; Y Kamisaki; T Suou; T Itoh; H Kawasaki
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

8.  Loss of heterozygosity and K-ras gene mutations in gastric cancer.

Authors:  G N Ranzani; B Renault; N S Pellegata; P Fattorini; E Magni; F Bacci; D Amadori
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

9.  Genetic control of susceptibility to diethylnitrosamine and dimethylbenzanthracene carcinogenesis in rats.

Authors:  M F Melhem; H W Kunz; T J Gill
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

10.  Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA.

Authors:  O Hino; S Tabata; Y Hotta
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.